Skip to main content
. Author manuscript; available in PMC: 2010 Jul 27.
Published in final edited form as: Arch Pediatr Adolesc Med. 2005 Sep;159(9):876–881. doi: 10.1001/archpedi.159.9.876

Table 1.

Families With KS With 2 Affected Siblings

Family No. Case No.* Age at Onset, y Interval, y Ethnicity No. of Criteria for KS Met Medical Records Reviewed Parental Interview Conducted No. of IVIG Doses Aneurysms
1 1 1 1.83 Filipino/Korean 4 Yes No 1 No
2 0.33 4 Yes No 1 No
2 1 5 1.42 Korean 5 Yes No 1 No
2 3 5 Yes No 1 No
3 1 4 2.50 Japanese 5 Yes No 1 No
2 6 5 Yes No 1 No
4 1 3 0.66 White 4 No Yes 2 Yes
1§ 3.66 4 No Yes 1
2 0.67 >1 4 No Yes 2 No
5 1 12 >1 White 5 Yes Yes 2 No
2 0.75 5 Yes Yes 1 No
2§ 5 >1 5 Yes Yes 1 No
6 1 6 0.23 White 4 Yes Yes 2 No
2 4 4 Yes Yes 1 No
7 1 10 0.06 White 4 No Yes 1 Yes
2 2.50 4 No Yes 0 No
8 1 4.17 4.67 White 3 Yes No 0 No
2 1.58 4 Yes No 1 No
9 1 0.46 0.02 Mexican American 5 Yes Yes 1 No
2 0.48 5 Yes Yes 2 No

Abbreviations: IVIG, intravenous immunoglobulin; KS, Kawasaki syndrome.

*

Numbered in the order of KS occurrence.

Time between KS episodes in the first and second child.

The total number possible was 5, including rash, conjunctival injection, changes in the oropharynx, changes in the extremities, or a cervical lymph node larger than 1.5 cm.

§

Recurrent case.